BioSpace News Archive

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today hosted a webcast and conference call highlighting its progress and key accomplishments in the first half of 2020.

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2020 after market close on Tuesday, August 11, 2020.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the “Company”), today announced the commencement of an underwritten public offering.

Limitless Venture Group, Inc. announces a stock consolidation plan to shore up liquidity, expedite its capital raising plan, meet existing financing obligations to our majority acquisition Rokin, close its second majority acquisition, KetoSports, and launch HempLink, its on-line hemp trading app.

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the pricing of the previously announced underwritten public offering of shares of its common stock.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Revolution Medicines, Inc. announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions.

ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc. , (AMRI), a leading global contract research, development, and manufacturing organization (CDMO), is undertaking research to investigate the potential of merimepodib to fight SARS-CoV-2, the virus that causes COVID-19, either as a stand-alone treatment or in combination with other antiviral agents or immune modulators. “As p

Signant Health, a leader in the clinical research technology industry, today announced the appointment of Roger Smith as Chief Executive Officer.

The American Pharmacists Association (APhA) and International Pharmaceutical Federation (FIP) stand with front-line pharmacists around the world who are caring for patients and rely heavily on the support of the World Health Organization (WHO) during the COVID-19 global crisis.